or
forgot password
  • cancer clinical trials in la porte, IN

  • Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer
    Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Mesothelioma
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Head and Neck Cancer
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer
    Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lung Cancer
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Brain and Central Nervous System Tumors
    Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Colorectal Cancer
    Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lung Cancer
    Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer, Sexual Dysfunction, Sexuality and Reproductive Issues
    Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Carcinoma of Unknown Primary, Pain
    Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Dermatologic Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Citalopram in Treating Postmenopausal Women With Hot Flashes
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer, Hot Flashes, Psychosocial Effects of Cancer and Its Treatment
    Methylphenidate in Treating Patients With Fatigue Caused by Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Colorectal Cancer, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Pain, Psychosocial Effects of Cancer and Its Treatment
    Assessing Older Patients With Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Unspecified Adult Solid Tumor, Protocol Specific
    Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer, Dermatologic Complications, Radiation Toxicity, Skin Reactions Secondary to Radiation Therapy
    Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lung Cancer
    Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lymphoma
    Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Malignant Mesothelioma
    Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Melanoma (Skin)
    Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Pancreatic Cancer
    Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Pancreatic Cancer
    Pregabalin in Treating Women With Hot Flashes
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer, Hot Flashes
    Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lung Cancer
    Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Breast Cancer